122 related articles for article (PubMed ID: 7626664)
1. Stimulation of urokinase expression by TNF-alpha requires the activation of binding sites for the AP-1 and PEA3 transcription factors.
Lengyel E; Klostergaard J; Boyd D
Biochim Biophys Acta; 1995 Jul; 1268(1):65-72. PubMed ID: 7626664
[TBL] [Abstract][Full Text] [Related]
2. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.
Gum R; Lengyel E; Juarez J; Chen JH; Sato H; Seiki M; Boyd D
J Biol Chem; 1996 May; 271(18):10672-80. PubMed ID: 8631874
[TBL] [Abstract][Full Text] [Related]
4. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras.
Lengyel E; Stepp E; Gum R; Boyd D
J Biol Chem; 1995 Sep; 270(39):23007-12. PubMed ID: 7559439
[TBL] [Abstract][Full Text] [Related]
5. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene.
Lengyel E; Wang H; Stepp E; Juarez J; Wang Y; Doe W; Pfarr CM; Boyd D
J Biol Chem; 1996 Sep; 271(38):23176-84. PubMed ID: 8798512
[TBL] [Abstract][Full Text] [Related]
6. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
Ried S; Jäger C; Jeffers M; Vande Woude GF; Graeff H; Schmitt M; Lengyel E
J Biol Chem; 1999 Jun; 274(23):16377-86. PubMed ID: 10347197
[TBL] [Abstract][Full Text] [Related]
7. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
Marschall C; Lengyel E; Nobutoh T; Braungart E; Douwes K; Simon A; Magdolen V; Reuning U; Degitz K
J Invest Dermatol; 1999 Jul; 113(1):69-76. PubMed ID: 10417621
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA.
Dear AE; Costa M; Medcalf RL
FEBS Lett; 1997 Feb; 402(2-3):265-72. PubMed ID: 9037208
[TBL] [Abstract][Full Text] [Related]
9. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.
D'Orazio D; Besser D; Marksitzer R; Kunz C; Hume DA; Kiefer B; Nagamine Y
Gene; 1997 Nov; 201(1-2):179-87. PubMed ID: 9409785
[TBL] [Abstract][Full Text] [Related]
10. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.
Lengye E; Singh B; Gum R; Nerlov C; Sabichi A; Birrer M; Boyd D
Oncogene; 1995 Dec; 11(12):2639-48. PubMed ID: 8545121
[TBL] [Abstract][Full Text] [Related]
11. L-tryptophan induces expression of collagenase gene in human fibroblasts: demonstration of enhanced AP-1 binding and AP-1 binding site-driven promoter activity.
Li L; Gotta S; Mauviel A; Varga J
Cell Mol Biol Res; 1995; 41(5):361-8. PubMed ID: 8867782
[TBL] [Abstract][Full Text] [Related]
12. Synergistic transcriptional activation of the mouse urokinase plasminogen activator (uPA) gene and of its enhancer activator protein 1 (AP1) site by cAMP and retinoic acid.
Mira-Y-Lopez R; Jaramillo S; Jing Y
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):909-16. PubMed ID: 9560322
[TBL] [Abstract][Full Text] [Related]
13. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta.
Chung KY; Agarwal A; Uitto J; Mauviel A
J Biol Chem; 1996 Feb; 271(6):3272-8. PubMed ID: 8621730
[TBL] [Abstract][Full Text] [Related]
14. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells.
Nerlov C; De Cesare D; Pergola F; Caracciolo A; Blasi F; Johnsen M; Verde P
EMBO J; 1992 Dec; 11(12):4573-82. PubMed ID: 1330539
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
Gum R; Wang H; Lengyel E; Juarez J; Boyd D
Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
[TBL] [Abstract][Full Text] [Related]
16. A labile repressor acts through the NFkB-like binding sites of the human urokinase gene.
Novak U; Cocks BG; Hamilton JA
Nucleic Acids Res; 1991 Jun; 19(12):3389-93. PubMed ID: 1905804
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha down-regulates human elastin gene expression. Evidence for the role of AP-1 in the suppression of promoter activity.
Kähäri VM; Chen YQ; Bashir MM; Rosenbloom J; Uitto J
J Biol Chem; 1992 Dec; 267(36):26134-41. PubMed ID: 1281483
[TBL] [Abstract][Full Text] [Related]
18. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion.
Simon C; Juarez J; Nicolson GL; Boyd D
Cancer Res; 1996 Dec; 56(23):5369-74. PubMed ID: 8968087
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of UEF3, a novel factor involved in the regulation of the urokinase and other AP-1 controlled promoters.
Berthelsen J; Vandekerkhove J; Blasi F
J Biol Chem; 1996 Feb; 271(7):3822-30. PubMed ID: 8632000
[TBL] [Abstract][Full Text] [Related]
20. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
